USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Green Cross Corporation

USPTO PatentsView assignee record - 40 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Green ranks #8,035 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 14 technology areas.

#8,035
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.7/100)
13.8
avg claims per patent
-24%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8035 · Foreign Corporation #8,035 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 40 grants
  • UPPER-Q #8,035/49,997
  • PHOTO-FINISH Ghost Autonomy
  • CPC-FOCUS A61P · 14 areas
  • INNOV-THIN 37.7/100
  • CLAIMS-RICH 13.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -24% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ghost Autonomy Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Green’s 37.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Green

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Green's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Green?

Each dot is one of Green’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Green’s own 13.8 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Green vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 39.940.040.04040.040.040.1 510152025 Granted patents (volume) Avg claims / patent Ghost Autonomy Inc. - 40, 19.6Ghost AutonomyGuandong Ocean University - 40, 6.83Guandong Ocean Un…Guardian Europe S.A.R.L. - 40, 18.12Guardian Europe R…Gunze Limited - 40, 6.1GunzeGuangdong Midea White Home Appliance Technology Innovation Center Co., Ltd. - 40, 14.18Guangdong Midea W…Hangzhou Zero Zero Technology Co., Ltd. - 40, 18.6Hangzhou Zero Zer…Heraeus Noblelight GMBH - 40, 14.45Heraeus NoblelightHZO, Inc. - 40, 14.75HZOGreen Cross Corporation - 40, 13.8Green Cross
Green vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Green's grants concentrate

Green Cross Corporation is a focused PatentsView assignee: 14 CPC subclasses with 70% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (8 grants) versus a trough of 1 in 2017. By volume, Green sits between Ghost Autonomy Inc. and HZO, Inc..

Green's three-year grant acceleration

Green Cross Corporation shows 8 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Green's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Green holds 40 patents at rank #8,039, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Green

By rank, the assignees closest to #8,039 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Green's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Green, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Green ranks #708 of 6,058 assignees by patent count in that subclass.

Green's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620172018201920202021202220232025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Green Cross Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 12.5%
2016 4 10.0%
2017 1 2.5%
2018 3 7.5%
2019 8 20.0%
2020 4 10.0%
2021 4 10.0%
2022 6 15.0%
2023 2 5.0%
2025partial year 3 7.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Green Cross Corporation's patent record in context - here's where to go next.

  • Green Cross Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #8,035 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Green Cross Corporation against Ghost Autonomy Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.